XML 58 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Information (Tables)
 12 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Revenue by Reportable Segment
The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
(in millions)202520242023
Pharmaceutical and Specialty Solutions$204,644 $210,019 $188,814 
Global Medical Products and Distribution12,636 12,381 12,222 
Nuclear and Precision Health Solutions1,578 1,369 1,197 
at-Home Solutions3,480 2,869 2,584 
OptiFreight® Logistics
324 274 240 
Other5,382 4,512 4,021 
Total segment revenue222,662 226,912 205,057 
Corporate (1)(84)(85)(78)
Total revenue$222,578 $226,827 $204,979 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
(in millions)202520242023
Pharmaceutical and Specialty Solutions$204,644 $210,019 $188,814 
Global Medical Products and Distribution12,636 12,381 12,222 
Nuclear and Precision Health Solutions1,578 1,369 1,197 
at-Home Solutions3,480 2,869 2,584 
OptiFreight® Logistics
324 274 240 
Other5,382 4,512 4,021 
Total segment revenue222,662 226,912 205,057 
Corporate (1)(84)(85)(78)
Total revenue$222,578 $226,827 $204,979 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
(in millions)202520242023
United States$220,993 $225,231 $203,440 
International1,669 1,681 1,617 
Total segment revenue222,662 226,912 205,057 
Corporate (1)(84)(85)(78)
Total revenue$222,578 $226,827 $204,979 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present revenue, expenses, and segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
2025
(in millions)PharmaGMPDOther Total
Segment revenue
$204,644 $12,636 $5,382 $222,662 
Cost of products sold
199,999 10,470 4,023 214,492 
SG&A2,387 2,031 843 5,261 
Total segment expenses
202,386 12,501 4,866 219,753 
Segment profit$2,258 $135 $516 $2,909 
Corporate (1)(634)
Consolidated operating earnings
$2,275 
2024
(in millions)PharmaGMPDOther Total
Segment revenue
$210,019 $12,381 $4,512 $226,912 
Cost of products sold
205,864 10,264 3,367 219,495 
SG&A2,140 2,025 722 4,887 
Total segment expenses
208,004 12,289 4,089 224,382 
Segment profit$2,015 $92 $423 $2,530 
Corporate (1)(1,287)
Consolidated operating earnings
$1,243 
2023
(in millions)PharmaGMPDOther Total
Segment revenue$188,814 $12,222 $4,021 $205,057 
Cost of products sold184,814 10,377 2,990 198,181 
SG&A2,119 1,992 635 4,746 
Total segment expenses186,933 12,369 3,625 202,927 
Segment profit$1,881 $(147)$396 $2,130 
Corporate (1)(1,378)
Consolidated operating earnings$752 
(1)Corporate revenue and expenses consists of the elimination of inter-segment revenue and other revenue and expenses not allocated to the segments.
Depreciation and Amortization and Additions to Property and Equipment by Reportable Segment
The following tables present depreciation and amortization and additions to property and equipment for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)202520242023
Pharmaceutical and Specialty Solutions$185 $184 $194 
Global Medical Products and Distribution212 205 173 
Other88 79 71 
Corporate305 242 254 
Total depreciation and amortization$790 $710 $692 

(in millions)202520242023
Pharmaceutical and Specialty Solutions$118 $76 $56 
Global Medical Products and Distribution133 136 191 
Other88 81 52 
Corporate208 218 182 
Total additions to property and equipment$547 $511 $481 
Assets by Reportable Segment
The following table presents total assets for the two reportable segments and the remaining operating segments, included in Other, and Corporate at June 30:
(in millions)20252024
Pharmaceutical and Specialty Solutions$37,313 $29,149 
Global Medical Products and Distribution
6,889 7,047 
Other4,045 2,606 
Corporate4,875 6,319 
Total assets$53,122 $45,121 
Property and Equipment, Net by Geographic Area
The following table presents property and equipment, net by geographic area:
(in millions)20252024
United States$2,422 $2,106 
International436 423 
Property and equipment, net$2,858 $2,529